Arca
Skip to content
Tools
Tools

EMBA: Probable arabinosyltransferase A

Protein in Mycobacterium tuberculosis that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on EMBA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved1

  • Ethambutol

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        EthambutolApprovedKanchan HealthcareSmall moleculeInhibitorArabinosyltransferase A inhibitor53

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        A Clinical Trial to Improve Treatment Outcomes Among Persons With Drug Sensitive Pulmonary TB Treated With 4 or 6 Months of High Dose Rifampicin Containing Regimens With or Without LevofloxacinEthambutolPhase 3RecruitingTuberculosis Research Centre, IndiaNov 18, 2026
        Ablation Versus Non-ablation Strategies for Non-puerperal Mastitis: A Prospective Real-world Registry StudyEthambutol—RecruitingSong HongpingOct 26, 2026
        Study of Combinations of Novel Promising Drugs for Pulmonary TuberculosisEthambutolPhase 2Not yet recruitingTASK Applied ScienceAug 19, 2026
        Rifapentine-Based Shorter Regimens for Tuberculosis and TB Infection in KazakhstanEthambutol—Not yet recruitingPublic Union "Kazakhstan Association of Phthisiopulmonologists"Jun 25, 2026
        Re-evaluating the Duration in Children of TB TreatmentEthambutolPhase 2Not yet recruitingUniversity of Wisconsin, MadisonJun 18, 2026
        Short-Course Regimens for DS-PTB in AIDS PatientsEthambutolNot applicableNot yet recruitingShanghai Public Health Clinical CenterMay 27, 2026
        Collect Data From Patients Receiving Standardized Anti-tuberculosis Therapy, Collect Monitoring Data, and Evaluate Treatment Efficacy and Potential Adverse Reactions.Ethambutol—Enrolling by invitationBeijing Chest HospitalMay 26, 2026
        A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)EthambutolPhase 2Not yet recruitingNational Institute of Allergy and Infectious Diseases (NIAID)May 19, 2026

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1877, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-20. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.